TY - JOUR
T1 - Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity
AU - Prat, Aleix
AU - Adamo, Barbara
AU - Fan, Cheng
AU - Peg, Vicente
AU - Vidal, Maria
AU - Galván, Patricia
AU - Vivancos, Ana
AU - Nuciforo, Paolo
AU - Palmer, Héctor G.
AU - Dawood, Shaheenah
AU - Rodón, Jordi
AU - Cajal, Santiago Ramony
AU - Campo, Josep Maria Del
AU - Felip, Enriqueta
AU - Tabernero, Josep
AU - Cortés, Javier
PY - 2013/12/18
Y1 - 2013/12/18
N2 - To improve our understanding of the biological relationships among different types of cancer, we have characterized variation in gene expression patterns in a set of 1,707 samples representing 6 human cancer types (breast, ovarian, brain, colorectal, lung adenocarcinoma and squamous cell lung cancer). In the unified dataset, breast tumors of the Basal-like subtype were found to represent a unique molecular entity as any other cancer type, including the rest of breast tumors, while showing striking similarities with squamous cell lung cancers. Moreover, gene signatures tracking various cancer- and stromal-related biological processes such as proliferation, hypoxia and immune activation were found expressed similarly in different proportions of tumors across the various cancer types. These data suggest that clinical trials focusing on tumors with common profiles and/or biomarker expression rather than their tissue of origin are warranted with a special focus on Basal-like breast cancer and squamous cell lung carcinoma.
AB - To improve our understanding of the biological relationships among different types of cancer, we have characterized variation in gene expression patterns in a set of 1,707 samples representing 6 human cancer types (breast, ovarian, brain, colorectal, lung adenocarcinoma and squamous cell lung cancer). In the unified dataset, breast tumors of the Basal-like subtype were found to represent a unique molecular entity as any other cancer type, including the rest of breast tumors, while showing striking similarities with squamous cell lung cancers. Moreover, gene signatures tracking various cancer- and stromal-related biological processes such as proliferation, hypoxia and immune activation were found expressed similarly in different proportions of tumors across the various cancer types. These data suggest that clinical trials focusing on tumors with common profiles and/or biomarker expression rather than their tissue of origin are warranted with a special focus on Basal-like breast cancer and squamous cell lung carcinoma.
UR - https://www.scopus.com/pages/publications/84891761779
U2 - 10.1038/srep03544
DO - 10.1038/srep03544
M3 - Article
SN - 2045-2322
VL - 3
JO - Scientific Reports
JF - Scientific Reports
M1 - 3544
ER -